Retrospective comparison of efficacy and safety of CAPOX and FOLFOX regimens as adjuvant treatment in patients with stage III colon cancer

OBJECTIVE: This study aimed to evaluate the efficacy and safety profile of capecitabine and oxaliplatin (CAPOX) and 5-fluorouracil, leucovorin, and oxaliplatin (FOLFOX) regimens as adjuvant treatment in patients with stage III colon cancer. METHODS: A total of 243 patients who received CAPOX and FOL...

Descripción completa

Detalles Bibliográficos
Autores principales: Degirmencioglu, Serkan, Tanrıverdi, Ozgur, Demiray, Atike Gokcen, Senol, Hande, Dogu, Gamze Gokoz, Yaren, Arzu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Clinical Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567718/
https://www.ncbi.nlm.nih.gov/pubmed/31099282
http://dx.doi.org/10.1177/0300060519848258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567718/
https://www.ncbi.nlm.nih.gov/pubmed/31099282
http://dx.doi.org/10.1177/0300060519848258

Ejemplares similares